TrialCardiovascular diabetology2025

Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis.

Ruth L Coleman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.